Clinical Trial Update: ErbB2 Positive Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial of ErbB2 (HER2) positive metastatic breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: China Medical University Hospital | Conditions: Metastatic Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED